These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35978363)

  • 1. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
    World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.
    Zhou P; Sun X; Zeng L; Zeng X; Xie G; Liu X; Tao K; Zhang P
    BMC Gastroenterol; 2024 Oct; 24(1):371. PubMed ID: 39427177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
    Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
    Wei YL; Cui YH; Dong YH; Shi WJ
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
    Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The largest lymph node defined response to neoadjuvant chemotherapy can predict long-term prognosis in locally advanced gastric cancer.
    Liu L; Wang Y; Liu T; Rao S; Zeng M
    Abdom Radiol (NY); 2023 Dec; 48(12):3653-3660. PubMed ID: 37755476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
    Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C
    BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Kano K; Yamada T; Komori K; Watanabe H; Takahashi K; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Dec; 28(13):8464-8472. PubMed ID: 34114182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a survival difference between older adult and younger adult patients with locally advanced gastric cancer with the same lymph node ratio?
    Yalkin O; Iflazoglu N; Deniz O; Uzunoglu MY; Turhan EI
    J Geriatr Oncol; 2022 Sep; 13(7):962-969. PubMed ID: 35739052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
    Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
    J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
    Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
    Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer.
    Hai ZX; Peng D; Li ZW; Liu F; Liu XR; Wang CY
    Sci Rep; 2024 Jul; 14(1):17689. PubMed ID: 39085386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
    Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
    J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer.
    Gulmez S; Senger AS; Uzun O; Omeroglu S; Ofluoglu C; Sert ZO; Oz A; Polat E; Duman M
    Niger J Clin Pract; 2021 Nov; 24(11):1602-1608. PubMed ID: 34782497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
    Wang J; Liu F; Ma W; Hu H; Li F
    Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.